Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins and Aspirin in Trauma
NCT02901067Phase 2Terminated
- Sponsor
- Denver Health
- Start
- Feb 2017
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin, aspirin in venous thromboembolism (VTE), acute lung injury (ALI), sponsored by Denver Health. Started Feb 2017; status: terminated.
02
Drugs
rosuvastatinaspirin
03
Conditions
venous thromboembolism (VTE)acute lung injury (ALI)
Beyond the preview
Go deeper on NCT02901067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901067.